Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice
Previous research has shown that mifepristone can prevent and reverse weight gain in animals and human subjects taking antipsychotic medications. This proof-of-concept study tested whether a more potent and selective glucocorticoid receptor antagonist could block dietary-induced weight gain and incr...
Saved in:
Main Authors: | Tomoko Asagami, Joseph K. Belanoff, Junya Azuma, Christine M. Blasey, Robin D. Clark, Philip S. Tsao |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Journal of Nutrition and Metabolism |
Online Access: | http://dx.doi.org/10.1155/2011/235389 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Retrospective on Nuclear Receptor Regulation of Inflammation: Lessons from GR and PPARs
by: Min-Dian Li, et al.
Published: (2011-01-01) -
The Effect of Glucocorticoid and Glucocorticoid Receptor Interactions on Brain, Spinal Cord, and Glial Cell Plasticity
by: Kathryn M. Madalena, et al.
Published: (2017-01-01) -
Enhanced Stability of Gr, h-BN and Gr/h-BN protected MoS2 flakes under laser illumination
by: Chak-Ming Liu, et al.
Published: (2025-01-01) -
Glucocorticoid receptors: The key of the response to steroid therapy in autoimmune hepatitis
by: Mohamed A. S. El-Guindi, et al.
Published: (2024-06-01) -
Effect of Donepezil on Group II mGlu Receptor Agonist- or Antagonist-Induced Amnesia on Passive Avoidance in Mice
by: Tomoaki Sato, et al.
Published: (2003-01-01)